In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Innovata Biomed Ltd.

Division of Vectura Group PLC

Latest From Innovata Biomed Ltd.

Recent Dealmaking (02/2004)

Summarizing the month in European dealmaking.

Recent Dealmaking (05/2003)

Summarizing the month in European dealmaking.

ImaRx Therapeutics Inc.

ImaRx Therapeutics Inc. aims to use a diagnostic contrast agent as a vehicle for drug and gene delivery. The company will encapsulate a therapeutic payload in a synthetic microbubble, inject it into the body, then apply ultrasound across the skin to rupture the microbubble at the targeted site. Shockwaves from the rupture are thought to permeate capillary walls and drive the drug or gene instantaneously into the targeted tissue.

Vectura Ltd.

Given the need to find more effective, and faster, ways of administering a widening range of drugs, many companies are looking to improve pulmonary drug delivery. One of Vectura's goals is improving existing dry powder inhalation systems.
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Therapeutic Areas
  • Respiratory, Pulmonary
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • UK
  • Parent & Subsidiaries
  • Vectura Group PLC
  • Senior Management
  • Mark Rowlands, Mgr., Bus. Dev.
  • Contact Info
  • Innovata Biomed Ltd.
    Phone: (44) 1727 837 341
    The Zigurrat
    Grosvenor Rd.
    St. Albans, AL1 3HW